FORM 4 [ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).         
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
                                                                                  
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response...
0.5
                      
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
                      
1. Name and Address of Reporting Person * Lefkowitz Steven W 2. Issuer Name and Ticker or Trading Symbol CorMedix Inc. [ CRMD ] 5. Relationship of Reporting Person(s) to Issuer (Check all applicable)__X__ Director                    _____ 10% Owner
_____ Officer (give title below)    _____ Other (specify below)
(Last)         (First)         (Middle)
C/O CORMEDIX INC., 400 CONNELL DRIVE, SUITE 5000
3. Date of Earliest Transaction (MM/DD/YYYY)
9/4/2020
(Street)
BERKELEY HEIGHTS, NJ 07922
(City)       (State)       (Zip)
4. If Amendment, Date Original Filed (MM/DD/YYYY)
 
6. Individual or Joint/Group Filing (Check Applicable Line) _X _ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3)
2. Trans. Date 2A. Deemed Execution Date, if any 3. Trans. Code
(Instr. 8)
4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4)
6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock  9/4/2020    P    3500.0000  A $4.0000  58283.0000  D 
 
Common Stock  9/4/2020    P    2215.0000  A $3.9800  60498.0000  D 
 
Common Stock                 30152.0000  I (1) Wade Capital Corp Money Purchase Plan 
Common Stock                 2000.0000  I  Reporting Person's Wife 

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security
(Instr. 3)
2. Conversion or Exercise Price of Derivative Security 3. Trans. Date 3A. Deemed Execution Date, if any 4. Trans. Code
(Instr. 8)
5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
6. Date Exercisable and Expiration Date 7. Title and Amount of Securities Underlying Derivative Security
(Instr. 3 and 4)
8. Price of Derivative Security
(Instr. 5)
9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Stock Option (Right to Buy Common Stock)  $5.6300                   (2) 2/25/2030  Common Stock  15000.0000    15000.0000  D 
 
Stock Option (Right to Buy Common Stock)  $8.3000                   (3) 1/10/2029  Common Stock  15000.0000    15000.0000  D 
 
Stock Option (Right to Buy Common Stock)  $2.8500                   (4) 2/16/2028  Common Stock  8000.0000    8000.0000  D 
 
Stock Option (Right to Buy Common Stock)  $2.2500                   (5) 6/25/2027  Common Stock  15000.0000    15000.0000  D 
 

Explanation of Responses:
(1)  The reporting person beneficially owns these securities through Wade Capital Corporation Money Purchase Plan (an entity for which he has voting and investment control).
(2)  These options were granted on 02/25/2020. The options vest monthly with full vesting on the one year anniversary of the date of grant, subject to continued service on the board.
(3)  These options were granted on 01/10/2019. The options are fully vested.
(4)  These options were granted on 2/16/2018. These options are fully vested.
(5)  These options were granted on 6/25/2017. These options are fully vested.

Remarks:
The Issuer effected a 1-for-5 reverse stock split of its common stock on March 26, 2019. All share and per share exercise price amounts shown in this Form 4 have been adjusted to reflect the reverse stock split.

Reporting Owners
Reporting Owner Name / Address
Relationships
Director 10% Owner Officer Other
Lefkowitz Steven W
C/O CORMEDIX INC.
400 CONNELL DRIVE, SUITE 5000
BERKELEY HEIGHTS, NJ 07922
X



Signatures
/s/ Steven W. Lefkowitz 9/9/2020
**Signature of Reporting Person Date
CorMedix (AMEX:CRMD)
Historical Stock Chart
From Sep 2020 to Oct 2020 Click Here for more CorMedix Charts.
CorMedix (AMEX:CRMD)
Historical Stock Chart
From Oct 2019 to Oct 2020 Click Here for more CorMedix Charts.